{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:57:23Z","timestamp":1792036643914,"version":"4.4.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RCP 2016"],"award-info":[{"award-number":["RCP 2016"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.yrtph.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T21:15:11Z","timestamp":1506287711000},"page":"342-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette"],"prefix":"10.1016","volume":"90","author":[{"given":"James","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Gaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-9902","authenticated-orcid":false,"given":"Frazer","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Minet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Breheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2017.09.008_bib1","series-title":"The Health Consequences of Smoking 50 Years of Progress: a Report of the Surgeon General","author":"US Department of Health Human Services","year":"2014"},{"key":"10.1016\/j.yrtph.2017.09.008_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13065-016-0221-9","article-title":"Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in\u00a0vitro exposure systems","volume":"10","author":"Adamson","year":"2016","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.yrtph.2017.09.008_bib4","series-title":"AFNOR publishes the world's first voluntary standards for electronic cigarettes and e-liquids","author":"AFNOR","year":"2015"},{"key":"10.1016\/j.yrtph.2017.09.008_bib5","first-page":"4","article-title":"Particle size distribution of e-cigarette aerosols and the relationship to Cambridge filter pad collection efficiency","volume":"26","author":"Alderman","year":"2014","journal-title":"Beitr\u00e4ge zur Tab. Int."},{"key":"10.1016\/j.yrtph.2017.09.008_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2017.09.008_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/15376516.2016.1217112","article-title":"Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke","volume":"26","author":"Azzopardi","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/1354750X.2014.1000970","article-title":"Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure","volume":"20","author":"Banerjee","year":"2015","journal-title":"Biomarkers"},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/aivt.2016.0024","article-title":"Differential gene expression using RNA-seq profiling in a reconstituted airway epithelium exposed to conventional cigarette smoke or electronic cigarette aerosols","volume":"3","author":"Banerjee","year":"2017","journal-title":"Appl Vitro Toxicol"},{"key":"10.1016\/j.yrtph.2017.09.008_bib12","series-title":"Presentation at the E-cigarette Summit","author":"Bates","year":"2013"},{"key":"10.1016\/j.yrtph.2017.09.008_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.tiv.2015.03.004","article-title":"Targeted omics analyses, and metabolic enzyme activity assays demonstrate maintenance of key mucociliary characteristics in long term cultures of reconstituted human airway epithelia","volume":"29","author":"Baxter","year":"2015","journal-title":"Toxicol Vitro"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.lungcan.2013.07.020","article-title":"Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study","volume":"82","author":"Berghmans","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.yrtph.2017.09.008_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.18001\/TRS.1.1.8","article-title":"Providing a science base for the evaluation of tobacco products","volume":"1","author":"Berman","year":"2015","journal-title":"Tob. Regul. Sci."},{"issue":"4","key":"10.1016\/j.yrtph.2017.09.008_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/em.22091","article-title":"The comparative tumour promotion assessment of e-cigarette and cigarettes using the in\u00a0vitro Bhas 42 cell transformation assay","volume":"58","author":"Breheny","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.yrtph.2017.09.008_bib19","series-title":"PAS 54115 Vaping products, including electronic cigarettes, formulations, e-shisha and directly-related products \u2013 Manufacture, importation, testing and labelling \u2013 Guide","author":"BSI","year":"2015"},{"key":"10.1016\/j.yrtph.2017.09.008_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/tc.2007.024158","article-title":"Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal","volume":"17","author":"Burns","year":"2008","journal-title":"Tob. Control"},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cbi.2015.05.025","article-title":"A\u00a0preliminary regional PBPK model of lung metabolism for improving species dependent descriptions of 1,3-butadiene and its metabolites","volume":"238","author":"Campbell","year":"2015","journal-title":"Chemico-Biological Interact."},{"key":"10.1016\/j.yrtph.2017.09.008_bib22","author":"Cancer Research UK"},{"key":"10.1016\/j.yrtph.2017.09.008_bib23","series-title":"E-cigarettes Safer than Smoking Says Long-term Study","author":"Cancer Research UK","year":"2017"},{"key":"10.1016\/j.yrtph.2017.09.008_bib24","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1158\/1055-9965.EPI-09-0948","article-title":"Abuse liability assessment of tobacco products including potential reduced exposure products","volume":"18","author":"Carter","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.yrtph.2017.09.008_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.tiv.2013.03.005","article-title":"The in\u00a0vitro cytotoxicity and genotoxicity of cigarette smoke particulate matter with reduced toxicant yields","volume":"27","author":"Combes","year":"2013","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.yrtph.2017.09.008_bib26","series-title":"Routine Analytical Machine for E-Cigarette Aerosol Generation and Collection \u2013 Definitions and Standard Conditions","author":"CORESTA","year":"2015"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.yrtph.2015.05.018","article-title":"An approach to ingredient screening and toxicological risk assessment of flavours in formulations","volume":"72","author":"Costigan","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.yrtph.2017.09.008_bib28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.yrtph.2016.10.003","article-title":"A\u00a0randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks","volume":"81","author":"Cravo","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.yrtph.2015.01.001","article-title":"The combination of two novel tobacco blends and filter technologies to reduce the in\u00a0vitro genotoxicity and cytotoxicity of prototype cigarettes","volume":"71","author":"Crooks","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib30","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.fct.2011.07.019","article-title":"A\u00a0novel application of the margin of exposure approach: segregation of tobacco smoke toxicants","volume":"49","author":"Cunningham","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib31","first-page":"21","article-title":"Tools for the prioritisation of tobacco smoke toxicants: an overview","volume":"38","author":"Cunningham","year":"2012","journal-title":"Rec. Adv. Tob. Sci."},{"key":"10.1016\/j.yrtph.2017.09.008_bib32","doi-asserted-by":"crossref","first-page":"35071","DOI":"10.1038\/srep35071","article-title":"Development, validation and application of a device to measure e-cigarette users' puffing topography","volume":"6","author":"Cunningham","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2017.09.008_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12889-016-3236-1","article-title":"Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes","volume":"16","author":"D'Ruiz","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.yrtph.2017.09.008_bib35","first-page":"229","article-title":"Real-time characterisation of e-cigarette use: the one million puffs study","volume":"6","author":"Dautzenberg","year":"2015","journal-title":"J.\u00a0Addict. Res. Ther."},{"key":"10.1016\/j.yrtph.2017.09.008_bib36","first-page":"374","volume":"vol. 3","author":"Dittrich","year":"2014"},{"key":"10.1016\/j.yrtph.2017.09.008_bib39","series-title":"EFSA\/WHO International Conference with Support of ILSI Europe on Risk Assessment of Compounds that Are Both Genotoxic and Carcinogenic","author":"European Food Safety Authority (EFSA)","year":"2006"},{"key":"10.1016\/j.yrtph.2017.09.008_bib40","series-title":"Guideline on Similar Biological Medicinal Products","author":"European Medicines Agency","year":"2014"},{"key":"10.1016\/j.yrtph.2017.09.008_bib41","series-title":"Guideline on the Qualification and Reporting of Physiologically Based Pharmacokinetic (PBPK) Modelling and Simulation EMA\/CHMP\/458101\/2016","author":"European Medicines Agency","year":"2016"},{"key":"10.1016\/j.yrtph.2017.09.008_bib42","unstructured":"European Parliament and the Council of the European Union Tobacco Products Directive., (2014). 2014\/40\/EU. http:\/\/ec.europa.eu\/health\/tobacco\/docs\/dir_201440_en.pdf. (Accessed 20 February 2017)."},{"key":"10.1016\/j.yrtph.2017.09.008_bib43","unstructured":"European Pharmacopeia., (2016). https:\/\/www.edqm.eu\/sites\/default\/files\/index9-1_e.pdf (Accessed 20 February 2017)."},{"key":"10.1016\/j.yrtph.2017.09.008_bib44","series-title":"The analysis of isotopically labelled propylene glycol in e-cigarettes","author":"Farmen","year":"2014"},{"key":"10.1016\/j.yrtph.2017.09.008_bib45","series-title":"Tobacco Science Research Conference, 69th Meeting","article-title":"The analysis of isotopically labelled propylene glycol in e-cigarettes","author":"Farmen","year":"2014"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/2042098614524430","article-title":"Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review","volume":"5","author":"Farsalinos","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.yrtph.2017.09.008_bib47","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1038\/srep11269","article-title":"Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and na\u00efve users (smokers)","volume":"5","author":"Farsalinos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2017.09.008_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1091581812461810","article-title":"Modification of smoke toxicant yields alters the effects of cigarette smoke extracts on endothelial migration: an in\u00a0vitro study using a cardiovascular disease model","volume":"31","author":"Fearon","year":"2012","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5993\/AJHB.41.1.2","article-title":"E-cigarette nicotine delivery: data and learnings from pharmacokinetic studies","volume":"41","author":"Fearon","year":"2016","journal-title":"Am. J. Health Behav."},{"key":"10.1016\/j.yrtph.2017.09.008_bib51","article-title":"Guidance for industry modified risk tobacco product applications","author":"Food and Drug Administration","year":"2012","journal-title":"Draft Guid."},{"key":"10.1016\/j.yrtph.2017.09.008_bib52","volume":"vol 77","author":"Food and Drug Administration","year":"2012"},{"key":"10.1016\/j.yrtph.2017.09.008_bib53","author":"Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.yrtph.2017.09.008_bib55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/tc.12.4.424","article-title":"Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke","volume":"12","author":"Fowles","year":"2003","journal-title":"Tob. Control"},{"key":"10.1016\/j.yrtph.2017.09.008_bib56","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.4155\/bio.14.136","article-title":"Application of CE\u2013MS to a metabonomics study of human urine from cigarette smokers and non-smokers","volume":"6","author":"Garcia-Perez","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.yrtph.2017.09.008_bib57","unstructured":"Gilbert, HA., (1965). Smokeless non tobacco cigarette. Patent US3200819."},{"key":"10.1016\/j.yrtph.2017.09.008_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/tobaccocontrol-2012-050859","article-title":"Levels of selected carcinogens and toxicants in vapour from electronic cigarettes","volume":"23","author":"Goniewicz","year":"2014","journal-title":"Tob. Control"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ntr\/ntw160","article-title":"Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study","volume":"19","author":"Goniewicz","year":"2017","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib60","series-title":"Proceedings of the Annual Meeting of the Society for Research on Nicotine and Tobacco","article-title":"A\u00a0proposed framework for PREP assessment","author":"Gregg","year":"2008"},{"issue":"6","key":"10.1016\/j.yrtph.2017.09.008_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/1354750X.2013.821523","article-title":"Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach","volume":"18","author":"Gregg","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.yrtph.2017.09.008_bib62","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/add.12659","article-title":"Electronic cigarettes: review of use, content safety, effects on smokers and potential for harm and benefit","volume":"109","author":"Hajek","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mrgentox.2003.10.014","article-title":"An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells","volume":"557","author":"Han","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.tiv.2009.12.019","article-title":"Cigarette smoke total particulate matter increases mucous secreting cell numbers in\u00a0vitro: a potential model of goblet cell hyperplasia","volume":"24","author":"Haswell","year":"2010","journal-title":"Toxicol Vitro"},{"issue":"5","key":"10.1016\/j.yrtph.2017.09.008_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/1354750X.2014.912354","article-title":"A\u00a0cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers","volume":"19","author":"Haswell","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.yrtph.2017.09.008_bib66","series-title":"A\u00a0Targeted Proteomic Comparison of Human Induced Sputum from Smokers and Non Smokers","author":"Haswell","year":"2016"},{"key":"10.1016\/j.yrtph.2017.09.008_bib67","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41598-017-00852-y","article-title":"Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in\u00a0vitro using normalized nicotine dose and RNA-seq-based toxicogenomics","volume":"7","author":"Haswell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2017.09.008_bib68","article-title":"Determination of \u201ctar\u201d, nicotine and carbon monoxide in mainstream tobacco smoke","author":"Health Canada","year":"1999","journal-title":"Health Can. Method T-115"},{"key":"10.1016\/j.yrtph.2017.09.008_bib69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yrtph.2017.03.012","article-title":"A\u00a0System Dynamics approach to assess the impact of launching a new nicotine product on population health outcomes","volume":"86","author":"Hill","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.yrtph.2017.09.008_bib72","series-title":"Interagency Coordinating Committee on the Validation of Alternative Methods \u201cIn\u00a0Vitro Cytotoxicity Test Methods for Estimating Starting Doses for Acute Oral Systematic Toxicity Testing\u201d","author":"ICCVAM","year":"2006"},{"key":"10.1016\/j.yrtph.2017.09.008_bib76","unstructured":"Institute for In\u00a0Vitro Sciences., (2017). http:\/\/www.iivs.org\/. (Accessed 20 February 2017)."},{"key":"10.1016\/j.yrtph.2017.09.008_bib77","series-title":"Scientific Standards for Studies on Modified Risk Tobacco Products","author":"Institute of Medicine, IOM","year":"2012"},{"issue":"6","key":"10.1016\/j.yrtph.2017.09.008_bib79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/15376516.2016.1170251","article-title":"A\u00a0framework for in\u00a0vitro systems toxicology assessment of e-liquids","volume":"26","author":"Iskandar","year":"2017","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.yrtph.2017.09.008_bib82","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio-2016-0108","article-title":"Multiplatform serum metabolic phenotyping combined with pathway mapping to identify biochemical differences in smokers","volume":"8","author":"Kaluarachchi","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.yrtph.2017.09.008_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.yrtph.2017.09.008_bib84","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/ntr\/ntv024","article-title":"Preliminary evaluation of a new German translated tobacco quality of life impact tool to discriminate between healthy current and former smokers and to explore the effect of switching smokers to a reduced toxicant prototype cigarette","volume":"17","author":"Kulasekaran","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib86","first-page":"51","article-title":"A\u00a0framework for the assessment of reduced risk tobacco and nicotine products","author":"Lowe","year":"2015","journal-title":"Rec. Adv. Tob. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/aivt.2016.0031","article-title":"Development of an adverse outcome pathway for the onset of hypertension by perturbation of endothelial nitric oxide bioavailability and oxidative stress","volume":"3","author":"Lowe","year":"2017","journal-title":"Appl. vitro Toxicol"},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/aivt.2016.0032","article-title":"The adverse outcome pathway for oxidative stress-mediated EGFR activation leading to decreased lung function","volume":"3","author":"Luettich","year":"2016","journal-title":"Appl. vitro Toxicol"},{"key":"10.1016\/j.yrtph.2017.09.008_bib89","series-title":"The Tobacco Atlas","author":"MacKay","year":"2006"},{"key":"10.1016\/j.yrtph.2017.09.008_bib91","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.chemrestox.6b00188","article-title":"Chemical composition of an e-cigarette aerosol \u2013 a quantitative comparison with cigarette smoke","volume":"29","author":"Margham","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2017.09.008_bib92","doi-asserted-by":"crossref","first-page":"L1248","DOI":"10.1152\/ajplung.00290.2006","article-title":"Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in\u00a0vitro","volume":"292","author":"Maunders","year":"2007","journal-title":"Am J Physiology - Lung Cell. Mol. Physiology"},{"key":"10.1016\/j.yrtph.2017.09.008_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0269881112458731","article-title":"Reducing harm from tobacco use","volume":"27","author":"McNeill","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib94","series-title":"E-cigarettes: an Evidence Update a Report Commissioned by Public Health England","author":"McNeill","year":"2015"},{"key":"10.1016\/j.yrtph.2017.09.008_bib95","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.tiv.2015.03.008","article-title":"Examination of the use of human sera as an exposure agent for in\u00a0vitro studies investigating the effects of cigarette smoking on cellular cardiovascular disease models","volume":"29","author":"McQuillan","year":"2015","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.yrtph.2017.09.008_bib97","first-page":"52","volume":"21","author":"Murphy","year":"2017"},{"key":"10.1016\/j.yrtph.2017.09.008_bib98","series-title":"National Centre for the Replacement, Refinement and Reduction of Animals in Research","author":"National centre for 3Rs","year":"2017"},{"key":"10.1016\/j.yrtph.2017.09.008_bib99","series-title":"Toxicity Testing in the 21st Century: a Vision and a Strategy","author":"National Research Council","year":"2007"},{"issue":"7","key":"10.1016\/j.yrtph.2017.09.008_bib100","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.tiv.2015.05.018","article-title":"Development of an in\u00a0vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol","volume":"29","author":"Neilson","year":"2015","journal-title":"Toxicol Vitro"},{"issue":"5","key":"10.1016\/j.yrtph.2017.09.008_bib101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000360220","article-title":"Estimating the harms of nicotine-containing products using the MCDA approach","volume":"20","author":"Nutt","year":"2014","journal-title":"Eur. J. Addict. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib102","series-title":"Test No. 471: Bacterial Reverse Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects","author":"OECD","year":"1997"},{"key":"10.1016\/j.yrtph.2017.09.008_bib103","series-title":"Test No, 476. In\u00a0Vitro Mammalian Cell Gene Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects","author":"OECD","year":"1997"},{"key":"10.1016\/j.yrtph.2017.09.008_bib104","series-title":"Test No. 487. In\u00a0Vitro Mammalian Cell Micronucleus Test, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects","author":"OECD","year":"2010"},{"key":"10.1016\/j.yrtph.2017.09.008_bib105","series-title":"Organisation for Economic Co-operation and Development \u201cGuidance Document on the in\u00a0Vitro BHAS 42 Cell Transformation Assay\u201d ENV\/JM\/Mono(2016) 1 Series on Testing & Assessment, No. 231","author":"OECD","year":"2016"},{"issue":"114","key":"10.1016\/j.yrtph.2017.09.008_bib109","first-page":"99","article-title":"Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes","volume":"21","author":"Polosa","year":"2016","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12931-016-0481-x","article-title":"Evidence for harm reduction in COPD smokers who switch to electronic cigarettes","volume":"17","author":"Polosa","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib111","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2015.11.007","article-title":"Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells","volume":"339","author":"Poussin","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2017.09.008_bib112","series-title":"Presentation at Biomarkers of Tobacco Exposure: a Public Workshop","article-title":"Lessons from clinical studies using biomarkers of exposure to assess toxicant exposure","author":"Proctor","year":"2015"},{"key":"10.1016\/j.yrtph.2017.09.008_bib113","series-title":"Utility of Biomarkers of Biological Effect as End-points for the Disease Relevant Assessment of Novel Tobacco and Nicotine Products as Potentially Reduced Risk Products Presentation at Biomarkers of Biological Effect","author":"Proctor","year":"2016"},{"key":"10.1016\/j.yrtph.2017.09.008_bib114","first-page":"1","article-title":"Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions","author":"Proctor","year":"2014","journal-title":"Rec. Adv. Tob. Sci."},{"issue":"1008","key":"10.1016\/j.yrtph.2017.09.008_bib115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/pgmj.2008.073759","article-title":"How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease","volume":"85","author":"Puntmann","year":"2009","journal-title":"Postgrad. Med. J."},{"issue":"12","key":"10.1016\/j.yrtph.2017.09.008_bib116","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1164\/rccm.200704-586UP","article-title":"Update in chronic obstructive pulmonary disease 2006","volume":"175","author":"Rabe","year":"2007","journal-title":"Am. J. Resp. Crit. Care"},{"key":"10.1016\/j.yrtph.2017.09.008_bib118","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.chroma.2017.02.050","article-title":"Chemical characterisation of aerosols emitted by electronic cigarettes using thermal desorption - gas chromatography - time of flight mass spectrometry","volume":"1497","author":"Rawlinson","year":"2017","journal-title":"J\u00a0Chromatogr. A"},{"key":"10.1016\/j.yrtph.2017.09.008_bib119","unstructured":"Robinson, J., (1930). Electric vaporizer. US patent US1775947."},{"key":"10.1016\/j.yrtph.2017.09.008_bib120","series-title":"The Chemical Components of Tobacco and Tobacco Smoke","author":"Rodgman","year":"2013"},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib121","first-page":"12","article-title":"Mainstream smoke chemistry and in\u00a0vitro and in\u00a0vivo toxicity of the reference cigarettes 3R4F and 2R4F","volume":"25","author":"Roemer","year":"2012","journal-title":"Beitr\u00e4ge zur Tab. Int."},{"key":"10.1016\/j.yrtph.2017.09.008_bib122","series-title":"Nicotine without Smoke-tobacco Harm Reduction","author":"Royal College of Physicians","year":"2016"},{"key":"10.1016\/j.yrtph.2017.09.008_bib124","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.yrtph.2016.10.001","article-title":"Evaluation of the tobacco heating system 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol","volume":"81","author":"Schaller","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib125","doi-asserted-by":"crossref","first-page":"A700","DOI":"10.1289\/ehp.114-a700","article-title":"Signs of the times: biomarkers in perspective","volume":"114","author":"Schmidt","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2017.09.008_bib126","doi-asserted-by":"crossref","DOI":"10.7326\/M16-1107","article-title":"Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study","author":"Shahab","year":"2017","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.yrtph.2017.09.008_bib127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yrtph.2013.02.007","article-title":"Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes","volume":"66","author":"Shepperd","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib128","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2458-13-690","article-title":"A\u00a0single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes","volume":"13","author":"Shepperd","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.yrtph.2017.09.008_bib129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yrtph.2015.04.016","article-title":"Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes","volume":"72","author":"Shepperd","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib130","first-page":"74","article-title":"A\u00a0device to measure a smoker's puffing topography and real-time puff-by-puff \u201ctar\u201d delivery","volume":"26","author":"Slayford","year":"2014","journal-title":"Beitr\u00e4ge zur Tabakforschung\/Contributions Tob. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib150","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.yrtph.2016.07.006","article-title":"Evaluation of the tobacco heating system 2.2. Part 1: description of the system and the scientific assessment program","volume":"81","author":"Smith","year":"2016","journal-title":"Reg. Tox. Pharm."},{"key":"10.1016\/j.yrtph.2017.09.008_bib132","series-title":"Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction","author":"Stratton","year":"2001"},{"key":"10.1016\/j.yrtph.2017.09.008_bib133","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/tx400410s","article-title":"Systems Toxicology: from basic research to risk assessment","volume":"27","author":"Sturla","year":"2014","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2017.09.008_bib135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/15376516.2016.1222473","article-title":"E-cigarette aerosols induce lower oxidative stress in\u00a0vitro when compared to tobacco smoke","volume":"26","author":"Taylor","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.yrtph.2017.09.008_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2017.06.001","article-title":"A\u00a0comparative assessment of e-cigarette aerosols and cigarette smoke on in\u00a0vitro endothelial cell migration","author":"Taylor","year":"2017","journal-title":"Tox Lett."},{"key":"10.1016\/j.yrtph.2017.09.008_bib137","first-page":"1","article-title":"Evaluation of nicotine pharmacokinetics and subjective effects following use of a novel nicotine delivery system","author":"Teichert","year":"2017","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrgentox.2016.10.005","article-title":"The mutagenic assessment of electronic-cigarettes and tobacco smoke using the Ames assay in strains TA98 and TA100","volume":"812","author":"Thorne","year":"2016","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2017.09.008_bib139","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.toxlet.2016.12.006","article-title":"The comparative in\u00a0vitro assessment of e-cigarette and cigarette smoke aerosols using the \u03b3H2AX assay and applied dose measurements","volume":"265","author":"Thorne","year":"2017","journal-title":"Tox Lett."},{"key":"10.1016\/j.yrtph.2017.09.008_bib140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/bmm.09.51","article-title":"Smoking and atherosclerotic cardiovascular disease: Part II: role of cigarette smoking in cardiovascular disease development","volume":"3","author":"Unverdorben","year":"2009","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.yrtph.2017.09.008_bib141","first-page":"351","article-title":"How tobacco smoke causes disease: the biology and behavioural basis for smoking\u2013attributable disease: a report of the surgeon general","author":"US Department of Health & Human Services","year":"2010","journal-title":"Surg. General"},{"issue":"8","key":"10.1016\/j.yrtph.2017.09.008_bib151","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1360-0443.2012.03791.x","article-title":"Clinical laboratory assessment of the abuse liability of an electronic cigarette","volume":"107","author":"Vansickel","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.yrtph.2017.09.008_bib142","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","article-title":"Adverse outcome pathway (AOP) development I: strategies and principles","volume":"142","author":"Villeneuve","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2017.09.008_bib143","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.yrtph.2015.12.003","article-title":"A\u00a0randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics","volume":"74","author":"Walele","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib144","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yrtph.2015.12.004","article-title":"A\u00a0randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: safety and subjective effects","volume":"74","author":"Walele","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2017.09.008_bib146","first-page":"89","article-title":"A\u00a0novel approach to assess the population health impact of introducing a modified risk tobacco product","volume":"72","author":"Weitkunat","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2017.09.008_bib152","author":"World Health Organisation"},{"key":"10.1016\/j.yrtph.2017.09.008_bib147","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/bmm.09.32","article-title":"Smoking and atherosclerotic cardiovascular disease: Part I: atherosclerotic disease processes","volume":"3","author":"Winkelmann","year":"2009","journal-title":"Biomarkers Med."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017302805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230017302805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:03:52Z","timestamp":1762365832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230017302805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":122,"alternative-id":["S0273230017302805"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.09.008","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British American Tobacco Ltd. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}